30 closest matches · ranked by relevance
Irritable Bowel Syndrome · Colitis, Ulcerative · Crohn Disease
Primary: Colonic-Mucosa Associated Microbial Species Per Compiled Participants in 5 Different Arms — 40; 30; 23; 23 microbial species population
Obesity
Primary: Stool Calories During OF and UF — 5.8; 8.9 percentage of calorie intake
Human Gut Microbiota
Primary: Bacteria Prevalence in Stool — 22.3; 20.9; 18.0; 25.5 percentage of bacterial genera in stool — p=<0.05
Sarcopenia
Primary: Percentage of Whole Body Lean Mass (%WBLM) — 67.3; 61.9 % of whole body mass
Premature Intestinal Microbiota · Necrotizing Enterocolitis · Late Onset Bloodstream Infection
Primary: The Composition of Bacteria Present, Established by Ultra-deep RNA Gene Sequencing, in Pre-morbid Faecal Samples From Neonates With Necrotizing Enterocolitis and…
Mechanisms, Defense
Primary: Gut Microbiota Composition — 58; 30; 0.04; 7.3 percentage of bacterial phyla
Ulcerative Colitis
Primary: Golimumab Induced Shifts in the Abundance of Bacterial Markers — 14965109899; 132857054401767; 12779328208; 12851286145 16S gene copies per gram of faeces
Gut Inflammation · Hypertension
Primary: Differential Gene Expression in Gut Epithelium — 29; 6 Differentially expressed gene
Intestinal Microbiota and Barrier Function
Primary: Change in Microbiota, as Measured by Change in Microbiota Composition, Including Presence of B. Adolescentis BD1 and B. Animalis Supsp Lactis BB-12 — 7.9; 9.1; 8.8; 6.0…
Clostridium Difficile
Primary: Shannon Diversity Index Measuring Change in Microbiome Diversity — 0.18; 0.14 Shannon index — p=0.71
Healthy Adults
Primary: Evaluation of the Changes in Microbiome Species Abundance and Diversity From Baseline Until End of Study (Day 35) — 27.00; 31.25; 27.00; 27.00 copies/ng DNA — p=<0.0001
Gut Health
Primary: Stool Short-chain Fatty Acids Production Following Each Intervention Between Mothers and Daughters — 50; 26; 41.7; 47.8 umol/g
Prader-Willi Syndrome · Obesity
Primary: Microbiome Analysis: Alpha Diversity — 4.89 Shannon index
Healthy Adult Subjects
Primary: Evaluation of the Levels of B.Infantis in Stool by Quantitative PCR — 3.33; 3.33; 3.33; 3.33 copies/ng DNA — p=<0.0001
Type 1 Diabetes
Primary: Change in the Gut Microbiome Profile — 818.5; 229; 1610; 177 species count
Non-Alcoholic Fatty Liver Disease · Obesity
Primary: Difference in the Distribution of Fecal Microbiota in Each Participant
Antibiotic Enterocolitis
Primary: Change in Mean Number of Colonic Submucosal Neurons/mm^2 in the Colon After Antibiotic Treatment — 0 neuronal cells/mm^2
Healthy Volunteers
Primary: Gastrointestinal Symptom Rating Scale — 18.7; 18.7; 17.3 units on a scale
Primary Sclerosing Cholangitis · Biliary Atresia
Primary: Determine the Benefit of Oral Vancomycin Therapy for Primary Sclerosing Cholangitis and Biliary Atresia — 10; 0; 0; 0 participants
End-Stage Renal Disease · Gut Microbiome Dysbiosis
Primary: Within Participant Variability in Microbiome Composition by Treatment Phase — 0.165; 0.175; 0.210 weighted unifrac distrance
Obesity
Primary: Percent Change From Baseline in Insulin Resistance Based on Insulin-Stimulated Glucose Uptake (M) During Hyperinsulinemic Euglycemic Clamp — -3; 5 percent change — p=0.16
Healthy Adults
Primary: To Evaluate the Effect of BSS on the Human Gut Microbiome. — 2 Number of different bacterial taxa — p=<0.05
Inflammation · Women's Health · Gastrointestinal Microbiome
Primary: C-reactive Protein — 160.7; 173.4; 211.4 ng/mL
Microbial Colonization
Primary: Phylum Level Mean Proportional Relative Abundance — 0.167; 0.0271; 0.686; 0.0391 % gram positive (+) for phylum
Microbiota
Primary: Change in Microbial Phylum Abundance (% of Total) Between Spice and Placebo — 65.1; 65.9; 58.7; 70.1 percentage of total bacteria — p=0.033
Crohn's Disease
Primary: Change in Disease Activity by Harvey Bradshaw Index — -5; -3 score on a scale
Healthy Conditions
Primary: Mucosal Surface Enlargement — 10.2; 9.9 percentage of muscular mucosae — p=<0.05
Obesity · Diabetes Mellitus, Type 2
Primary: Number of Participants With Complete Diabetes Remission at 3 Months — 8; 5 Participants
Inflammation
Primary: Changes in Diversity of Gut Microbiota 16S rRNA Gene Sequences With Regard to Time. — 316.383; 302.400; 283.058 Avg. Operational Taxonomic Units
Inflammatory Bowel Diseases (IBD) · Crohn's Disease (CD) · Ulcerative Colitis (UC)
Primary: Number of Occurrences of Adverse Events at 6 Months According to Adverse Event Term — 11; 5; 5; 3 Events